Orange Book product · Brand (NDA)
MORPHABOND ER
MORPHINE SULFATE
At a glance
Oct 02, 2015
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 02, 2015
10 yr 10 mo ago
Today
Patent 10314788 expires
Listed drug product patent expiration.
Aug 12, 2028
in 2 yr 2 mo
Patent 7955619 expires
Listed drug product patent expiration.
Aug 12, 2028
in 2 yr 2 mo
Pharmaceutical detail
Active ingredient
MORPHINE SULFATE
Strength
15MG
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 206544
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2017ARYMO ERBrand (NDA)
NDA 208603 · ZYLA
- 2013MORPHINE SULFATEBrand (NDA)
NDA 204223 · FRESENIUS KABI USA
- 2011MORPHINE SULFATEBrand (NDA)
NDA 202515 · HOSPIRA INC
- 2011MORPHINE SULFATEBrand (NDA)
NDA 201517 · CHARTWELL MOLECULAR
- 2008MORPHINE SULFATEBrand (NDA)
NDA 022195 · HIKMA
- 2007KADIANBrand (NDA)
NDA 020616 · ALLERGAN
- 2004DEPODURBrand (NDA)
NDA 021671 · PACIRA PHARMS INC
- 2002AVINZABrand (NDA)
NDA 021260 · KING PHARMS LLC
- 1996MORPHINE SULFATEBrand (NDA)
NDA 020631 · SPECGX LLC
- 1992MORPHINE SULFATEBrand (NDA)
NDA 019917 · ICU MEDICAL INC
- 1992MORPHINE SULFATEBrand (NDA)
NDA 019916 · ICU MEDICAL INC
- 1990MORPHINE SULFATE (AUTOINJECTOR)Brand (NDA)
NDA 019999 · MERIDIAN MEDCL TECHN
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10314788 | Aug 12, 2028 | in 2 yr 2 mo | Product |
| 7955619 | Aug 12, 2028 | in 2 yr 2 mo | Product |

